Stage 0 Pancreatic Cancer AJCC v8 Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

Indication	Status	Phase
DBCOND0121165 (Stage 0 Pancreatic Cancer AJCC v8)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04539808	NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer	Treatment	Calcium (DB01373) Camptothecin (DB04690) Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Levoleucovorin (DB11596) Losartan (DB00678) Oxaliplatin (DB00526)